Figure 6.
Ubenimex regulated cell cycle in cooperation with anticancer drugs. Compared to controls without drug (white), Ube (light gray) decreased the percentage of cells in the G0/G1 cell cycle phase. At 48 h, HuH7 cells and PLC/PRF/5 cells treated with 5-FU, CDDP, DXR and SOR combined with Ube (black) showed significantly smaller percentages of cells in the G0/G1 phase and larger percentages of cells in the S/G2/M phases, compared to the percentages observed with anticancer drugs alone (dark gray), (mean ± SD, from three different replicates) *P<0.05.
